WO2009089534A3 - Compositions et procédés pour le traitement d'infections virales provoquées par un virus grippal - Google Patents

Compositions et procédés pour le traitement d'infections virales provoquées par un virus grippal Download PDF

Info

Publication number
WO2009089534A3
WO2009089534A3 PCT/US2009/030753 US2009030753W WO2009089534A3 WO 2009089534 A3 WO2009089534 A3 WO 2009089534A3 US 2009030753 W US2009030753 W US 2009030753W WO 2009089534 A3 WO2009089534 A3 WO 2009089534A3
Authority
WO
WIPO (PCT)
Prior art keywords
flu
oil
methods
influenza
compositions
Prior art date
Application number
PCT/US2009/030753
Other languages
English (en)
Other versions
WO2009089534A2 (fr
Inventor
Robert Bowker
Original Assignee
Knockout Technologies, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knockout Technologies, Ltd. filed Critical Knockout Technologies, Ltd.
Publication of WO2009089534A2 publication Critical patent/WO2009089534A2/fr
Publication of WO2009089534A3 publication Critical patent/WO2009089534A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne des procédés et compositions pour le traitement ou la prévention d'infections provoquées par des virus grippaux comprenant la grippe A, la grippe B, la grippe C et leurs mutants. Les procédés de l'invention utilisent des compositions pharmaceutiques comprenant du peroxyde d'hydroxyde (H2O2), de l'huile de terpène orange, de l'huile de valence orange et un support pharmaceutiquement acceptable. Dans un mode de réalisation, la composition pharmaceutique comprend en outre un émulsifiant non ionique (par exemple, le polysorbate 80). Dans d'autres modes de réalisation, la composition comprend également de l'origan, de l'huile de cumin, de l'essence de cassis, de l'essence de lavande, de l'huile de Mélaleuca à feuilles alternes et de l'huile d'olive. Divers sous-types de virus grippaux peuvent être traités au moyen des matériaux et procédés de l'invention et comprennent, sans s'y limiter, les sous-types H1N1, H1N2, H2N2, H3N2, H3N8, H5N1, H5N3, H5N8, H5N9, H7N1, H7N7, H9N2, et H10N7 y compris les sous-types suivants couramment connus sous les noms « grippe espagnole », « grippe asiatique », « grippe de Hong Kong », « grippe aviaire », « grippe porcine », « grippe équine » et « grippe canine ».
PCT/US2009/030753 2008-01-10 2009-01-12 Compositions et procédés pour le traitement d'infections virales provoquées par un virus grippal WO2009089534A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2019008P 2008-01-10 2008-01-10
US61/020,190 2008-01-10

Publications (2)

Publication Number Publication Date
WO2009089534A2 WO2009089534A2 (fr) 2009-07-16
WO2009089534A3 true WO2009089534A3 (fr) 2010-08-12

Family

ID=40853786

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/030753 WO2009089534A2 (fr) 2008-01-10 2009-01-12 Compositions et procédés pour le traitement d'infections virales provoquées par un virus grippal

Country Status (1)

Country Link
WO (1) WO2009089534A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2527688C2 (ru) * 2010-02-27 2014-09-10 Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" Способ лечения инфекционных заболеваний, вызванных вирусом гриппа с типом поверхностого антигена н1n1 и лекарственное средство для лечения инфекционных заболеваний, вызванных вирусом гриппа с типом поверхностного антигена н1n1
JP5848938B2 (ja) * 2011-10-05 2016-01-27 株式会社エス・アイ・ティー 口腔用組成物の製造方法
US20130158127A1 (en) * 2011-12-14 2013-06-20 Jean-Christophe Sergere Tea tree oil derivatives
CN108220221A (zh) * 2017-12-22 2018-06-29 吉林冠界生物技术有限公司 一种全悬浮细胞培养重组禽流感亚型病毒的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127489A1 (en) * 2002-10-24 2006-06-15 Michael Crothers Targeted delivery
US20060204467A1 (en) * 2005-03-08 2006-09-14 Ecolab Inc. Hydroalcoholic antimicrobial composition with skin health benefits
US20070105741A1 (en) * 2005-09-27 2007-05-10 Knockout Technologies, Ltd. Disinfectant compositions and methods of use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127489A1 (en) * 2002-10-24 2006-06-15 Michael Crothers Targeted delivery
US20060204467A1 (en) * 2005-03-08 2006-09-14 Ecolab Inc. Hydroalcoholic antimicrobial composition with skin health benefits
US20070105741A1 (en) * 2005-09-27 2007-05-10 Knockout Technologies, Ltd. Disinfectant compositions and methods of use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HECKERT R.A. ET AL.: "Efficacy of vaporized hydrogen peroxide against exotic animal viruses.", APPLIED AND ENVIRONMENTAL MICROBIOLOGY., vol. 63, no. 10, October 1997 (1997-10-01), pages 3916 - 3918 *

Also Published As

Publication number Publication date
WO2009089534A2 (fr) 2009-07-16

Similar Documents

Publication Publication Date Title
ECSP17064986A (es) Compuestos antivirales
MY141003A (en) Materials and methods for treating viral infections with a cysteamine compound
SV2005001920A (es) " compuestos nucleosidos para el tratamiento de infecciones virales "
CL2008001005A1 (es) Compuestos derivados de azufre, inhibidores de la serina proteasa ns3 del virus de la hepatitis c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos asociados a la proteasa de hcv.
ATE530561T1 (de) 3-ether- und 3-thioether-substituierte ciclosporinderivate zur behandlung und prävention einer hepatitis-c-infektion
BRPI1013394A2 (pt) "composto, composição farmacêutica, uso do composto, e, método para tratar um paciente infectado com virus da hepatite c."
CR11310A (es) Espiro-Pirrolidinas y su uso contra infeccion por el virus de Hepatitis C (HCV) y por el virus de Inmunodeficiencia Humana (VIH)
CL2011002494A1 (es) Compuestos derivados de 7-aza-di-espiro-[3.0.4.1]-decan-8-carboxamida; composición farmacéutica que los comprenden; y uso para el tratamiento de un trastorno asociado con el virus de la hepatitis c (hcv) y el virus de inmunodeficiencia humana (vih).
BRPI0822335A2 (pt) inibidores do vírus da hepatite c
WO2007041487A3 (fr) Peptides inhibiteurs d'infections virales
WO2008133704A3 (fr) Composés antimicrobiens et antiviraux et leurs procédés d'utilisation
CL2007003299A1 (es) Compuestos derivados de macrociclos, inhibidores del virus de la hepatitis c; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
CL2009000305A1 (es) Compuestos derivados de 2-aril-sustituido-1-benzofurano-3-carboxamida, inhibidores de la polimerasa ns5b; composicion farmaceutica; y su uso en el tratamiento de una enfermedad causada por el virus de la hepatitis c (hcv).
MX2011007195A (es) Derivado de ciclosporina para el uso en el tratamiento de infección de virus de hepatitis c (vhc) y virus de inmunodeficiencia humana (vih).
CL2007002671A1 (es) Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc.
WO2009089534A3 (fr) Compositions et procédés pour le traitement d'infections virales provoquées par un virus grippal
ECSP11011101A (es) Compuestos cicloundecadepsipéptidos y el uso de dichos compuestos como un medicamento
MY153290A (en) Multivalent avian influenza vaccines
SV2005001919A (es) Compuestos nucleosidos para el tratamiento de infecciones virales
WO2007076091A3 (fr) Traitement d’infections virales utilisant un inhibiteur de facteur tissulaire
WO2009023356A3 (fr) Matériaux et procédés pour traiter les infections par le virus de la grippe
WO2009152519A3 (fr) Nouveaux peptides antiviraux contre le virus de la grippe
RS53216B (en) HERBAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF VIRAL DISEASES TRANSMITTED BY THE BLOOD, AS DISEASES CAUSED BY HUMAN IMMUNODEFICIENCY (HIV) OR HEPATITIS C VIRUS
WO2010128016A3 (fr) Agonistes du récepteur par2 utilisés dans le traitement ou la prévention des infections du virus de la grippe a
ATE499108T1 (de) Verwendung von extrakten von cistus incanus zur herstellung eines medikaments zur prävention und/oder behandlung von grippe

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09700373

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09700373

Country of ref document: EP

Kind code of ref document: A2